Currently out of the existing stock ratings of Stan Berenshteyn, 19 are a BUY (36.54%), 4 are a SELL (7.69%), 29 are a HOLD (55.77%).

Stan Berenshteyn

Work Performance Price Targets & Ratings Chart

Analyst Stan Berenshteyn, currently employed at WELLS FARGO, carries an average stock price target met ratio of 66.35% that have a potential upside of 14.6% achieved within 79 days.

Stan Berenshteyn’s has documented 105 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ACCD, Accolade  at 11-Oct-2024.

Wall Street Analyst Stan Berenshteyn

Analyst best performing recommendations are on AMWL (AMERICAN WELL CORP).
The best stock recommendation documented was for AMWL (AMERICAN WELL CORP) at 2/28/2022. The price target of $80 was fulfilled within 1 day with a profit of $4.6 (5.44%) receiving and performance score of 54.37.

Average potential price target upside

OMCL Omnicell ACCD Accolade  GDRX Goodrx Holdings  HQY HealthEquity DOCS Doximity HCAT Health Catalyst TDOC Teladoc VEEV Veeva Systems AMWL American Well Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$48

$5.38 (12.62%)

$38

8 days ago

12/17 (70.59%)

$5.05 (11.76%)

117

Hold

$37

$-5.62 (-13.19%)

$28

1 months 24 days ago

4/5 (80%)

$-7.8 (-17.41%)

68

Hold

$30

$-12.62 (-29.61%)

$26

2 months 15 days ago

6/10 (60%)

$-9.22 (-23.51%)

92

Buy

$44

$1.38 (3.24%)

$49

2 months 15 days ago

1/3 (33.33%)

$4.78 (12.19%)

21

Buy

$39

$-3.62 (-8.49%)

$66

11 months 14 days ago

13/18 (72.22%)

$8.56 (28.12%)

113

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Stan Berenshteyn is most bullish on?

Potential upside of $24.58 has been obtained for HQY (HEALTHEQUITY)

Which stock is Stan Berenshteyn is most reserved on?

Potential downside of -$24.31 has been obtained for DOCS (DOXIMITY)

What Year was the first public recommendation made by Stan Berenshteyn?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?